(Q71835777)

English

Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues

scientific article published on 01 January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

author name string

C Bouchet-Bernet

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

F Spyratos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

C Andrieu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Deytieux

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

V Bécette

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J Oglobine

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

141-146

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01807159

0 references

Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator system in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01807159

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944332%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71835777&oldid=1753608255"